Loading
The Oregon Administrative Rules contain OARs filed through September 15, 2014
 
QUESTIONS ABOUT THE CONTENT OR MEANING OF THIS AGENCY'S RULES?
CLICK HERE TO ACCESS RULES COORDINATOR CONTACT INFORMATION

 

BOARD OF OPTOMETRY

 

DIVISION 80

PHARMACEUTICAL AGENTS

852-080-0020

Designation of Topical Formulary

Pursuant to ORS 683.010(3) and 683.270(j), optometric physicians are qualified to use, administer, and prescribe topical pharmaceutical agents as designated by the Oregon Board of Optometry. The following formulary of pharmaceutical agents for topical use in the practice of optometry are designated, subject to the conditions in 852-080-0030:

(1) Category 1 — Ocular lubricants, artificial tears, and irrigating solutions;

(2) Category 2 — Mydriatics;

(3) Category 3 — Cycloplegics;

(4) Category 4 — Anesthetics;

(5) Category 5 — Dyes;

(6) Category 6 — Miotics;

(7) Category 7 — Astringents and antiseptics;

(8) Category 8 — Caustic agents;

(9) Category 9 — Antihistamines and decongestants;

(10) Category 10 — Anti-louse agents;

(11) Category 11 — Hyperosmotics;

(12) Category 12 — Anti-infectives (antibiotics, anti-virals, anti-fungals);

(13) Category 13 — Anti-glaucoma and ocular hypotensives;

(14) Category 14 — Anti-inflammatories;

(15) Category 15 — Any combination of the above agents;

(16) Category 16 — Other agents as approved by the Board.

Stat. Auth.: ORS 182 & 683
Stats. Implemented: ORS 683.010, 683.270 & 182.466
Hist.: OP 1-1994, f. 5-4-94, cert. ef. 5-9-94; OPT 1-2000, f. & cert. ef. 3-15-00; OPT 1-2002, f. & cert. ef. 7-26-02; OPT 1-2013, f. & cert. ef. 1-3-13

852-080-0025

Adoption of Nontopical Formulary

Pursuant to ORS 683.010(3) optometric physicians are qualified to use, administer, and prescribe nontopical pharmaceutical agents adopted by the Council on Optometric Nontopical Formulary under ORS 683.240(2) and approved by the Board. The Oregon Board of Optometry adopts the following nontopical formulary subject to the conditions in 852-080-0030:

(1) Category 17 — Anesthetics;

(2) Category 18 — Analgesics;

(3) Category 19 — Dyes;

(4) Category 20 — Anti-allergy agents;

(5) Category 21 — Anti-infectives (antibiotics, anti-virals, anti-fungals);

(6) Category 22 — Anti-glaucoma and ocular hypotensives;

(7) Category 23 — Anti-inflammatory agents;

(8) Category 24 — Any combination of the above agents;

(9) Category 25 — Emergency use agents.

Stat. Auth.: ORS 683 & 182
Stats. Implemented: ORS 683.240 & 182.466
Hist.: OPT 1-2002, f. & cert. ef. 7-26-02; OPT 1-2013, f. & cert. ef. 1-3-13

852-080-0030

Conditions of Formulary Application

The following conditions apply to the formulary of pharmaceutical agents in 852-080-0020 and 852-080-0025:

(1) Optometric physicians certified for Topical Therapeutic Pharmaceutical Agents (TPA), Nontopical Therapeutic Pharmaceutical Agents (AT) or Nontopical Therapeutic Pharmaceutical Agents with Injections (ATI) may use, administer, and prescribe any and all over-the-counter pharmaceutical agents.

(2) Optometric physicians certified for topical TPA use may use, administer and prescribe topical agents in Categories 1-16.

(3) Optometric physicians certified for nontopical TPA use have the designation “AT” or “ATI” printed on their licenses, and may use, administer and prescribe topical and nontopical agents in Categories 1-24 as indicated for procedures that are permitted under OAR Chapter 852, Division 20 Standards of Optometric Practice.

(4) Glaucoma Treatment:

(a) Optometric physicians treating a patient with antiglaucoma medication must consult with an ophthalmologist if:

(A) The glaucoma progresses despite the use of two glaucoma medications;

(B) More than two medications are required to control the glaucoma; or

(C) A secondary glaucoma develops;

(b) Glaucoma is considered to be progressing if, in comparison to prior examinations, there is a reproducible worsening of the patient’s visual field as measured by standard threshold testing or if there is a worsening of the patient’s optic nerve as measured by direct observation or standard imaging technology or by rising eye pressure despite the use of two or more medications;

(c) Glaucoma is considered to be under control if target eye pressure, individualized for each patient, is maintained with no abnormal glaucomatous progression; and

(d) A combination medication that contains two pharmacologic agents is considered one medication.

(5) Optometric physicians certified for nontopical TPA must consult with a doctor of medicine or doctor of osteopathy, licensed under ORS Chapter 677, before extending treatment with nontopical corticosteriods or Schedule III analgesics beyond seven days.

(6) Optometric physicians should be diligent in preventing the diversion of drugs for illegitimate purposes. Upon application, active status licensees are granted access to the Oregon Prescription Drug Monitoring Program of the Oregon Health Authority to research controlled substance information on their patients; under ORS Chapter 431, fees for the program are required to be collected at the time of annual active license renewal by the Board and allow doctors to register and use the program at no additional charge.

(7) Optometric physicians may not use, administer or prescribe agents classified principally as anti-neoplastics.

(8) Optometric physicians may use or administer pharmaceutical agents in cases of emergency requiring immediate attention.

(9) Optometric physicians certified for nontopical TPA with injections (ATI) use may administer subcutaneous and subconjunctival injections. Sub-Tenon, retrobulbar, intraocular and botulinum toxin injections are excluded.

(10) Optometric physicians certified for nontopical TPA use, may administer oral pre-medication for light sedation. Conscious sedation, deep sedation and general anesthesia are excluded.

(11) Optometric physicians certified for topical or nontopical TPA use may prescribe and dispense therapeutic contact lenses that include pharmaceutical agents listed on the topical formulary in OAR 852-80-0020.

Stat. Auth.: ORS 683 & 182
Stats. Implemented: ORS 683.240, 683.270 & 182.466
Hist.: OP 1-1994, f. 5-4-94, cert. ef. 5-9-94; OPT 4-1998, f. 6-25-98, cert. ef. 7-1-98; OPT 1-2000, f. & cert. ef. 3-15-00; OPT 1-2002, f. & cert. ef. 7-26-02; OPT 2-2006, f. 3-20-06, cert. ef. 4-1-06; OPT 2-2007, f. 12-7-07 & cert. ef. 1-1-08; OPT 1-2008, f. 6-25-08, cert. ef. 7-1-08; OPT 1-2013, f. & cert. ef. 1-3-13

852-080-0040

Certification to Use Pharmaceutical Agents

(1) Topical TPA Certification (T) for inactive status licensee: Any optometric physician licensed in Oregon in inactive status who elects to become TPA certified must:

(a) Pass the National Board of Examiners in Optometry’s “Treatment and Management of Ocular Disease” (TMOD) or have passed a 100-hour TPA course approved by the Board and have been continuously practicing using therapeutic pharmaceutical agents in another state or states, and be without disciplinary incident;

(b) Pay a $75 TPA examination and licensure fee for topical TPA certification; and

(c) Obtain a license from the Oregon Board of Optometry indicating “Certified to use Topical Therapeutic Pharmaceutical Agents.”

(2) Nontopical TPA Certification (AT) for active status licensee: Before using nontopical therapeutic pharmaceutical agents as listed in this rule, any doctor of optometry licensed in Oregon in active status must:

(a) Meet Topical TPA Certification;

(b) Pass a didactic Nontopical TPA course of at least 23 hours approved by the Board or pass the National Board of Examiners in Optometry’s “Treatment and Management of Ocular Disease” (TMOD), year 2002 or subsequent examination;

(c) Pay a $75 TPA examination and licensure fee for nontopical TPA certification;

(d) Obtain a license from the Oregon Board of Optometry indicating “Certified to use Topical and Nontopical Therapeutic Pharmaceutical Agents”; and

(e) Acquire and maintain Board-approved CPR certification designed for professional health care providers. The CPR certification standard is the American Heart Association’s BLS Healthcare Providers Course or its equivalent, as determined by the Board. This CPR course must be a hands-on course; online CPR courses will not be approved by the Board for initial CPR certification:

(A) After the initial CPR certification, the Board will accept a Board-approved BLS Healthcare Providers Online Renewal course for license renewal. A CPR certification card with an expiration date must be received from the CPR provider as documentation of CPR certification;

(B) The Board considers the CPR expiration date to be the last day of the month that the CPR instructor indicates that the certification expires;

(C) Documentation of CPR certification is due with the licensee’s annual license renewal as indicated in OAR 852-050-0006. Failure to maintain current CPR certification will result in immediate automatic loss of Nontopical TPA certification. The Nontopical TPA certification will not be reinstated until the CPR certification deficiency has been corrected; and

(D) Any licensee whose Nontopical TPA certification is lost due to expiration of their CPR certification is subject to a late CPR fee of $50 to have the Nontopical TPA certification reinstated. The fee must be received before the Nontopical TPA certification will be reinstated.

(3) Nontopical TPA Certification (AT) for inactive status licensee: Any doctor of optometry licensed in Oregon in inactive status must:

(a) Meet all criteria for Topical TPA Certification in OAR 852-080-0040(1);

(b) Pass a didactic Nontopical TPA course of at least 23 hours approved by the Board or pass the National Board of Examiners in Optometry’s “Treatment and Management of Ocular Disease” (TMOD) year 2002 or subsequent examination;

(c) Pay a $75 TPA examination and licensure fee for nontopical TPA certification;

(d) Obtain a license from the Oregon Board of Optometry indicating “Certified to use Topical and Nontopical Therapeutic Pharmaceutical Agents”; and

(e) Acquire Board-approved CPR certification designed for professional healthcare providers. The CPR certification standard is the American Heart Association’s BLS Healthcare Providers Course or its equivalent, as determined by the Board. This CPR course must be a hands-on course; online CPR courses will not be approved by the Board for initial CPR certification. A CPR certification card with an expiration date must be received from the CPR provider. The Board considers the CPR expiration date to be the last day of the month that the CPR instructor indicates that the certification expires.

(4) Nontopical TPA Certification with Injections (ATI) for active status licensee: Before using nontopical therapeutic pharmaceutical agents with injections as listed in this rule, any doctor of optometry licensed in Oregon in active status must:

(a) Pass a Board-approved Nontopical TPA course of at least 23 hours or pass the National Board of Examiners in Optometry’s “Treatment and Management of Ocular Disease” (TMOD) year 2002 or subsequent examination;

(b) Pass a Nontopical TPA injection workshop of at least seven hours approved by the Board or provide proof of equivalent training acceptable to the Board;

(c) Pay a $75 TPA examination and licensure fee for nontopical TPA certification;

(d) Obtain a license from the Oregon Board of Optometry indicating “Certified to use Topical and Nontopical Therapeutic Pharmaceutical Agents with Injections”; and

(e) Acquire and maintain Board-approved CPR certification designed for professional health care providers. The CPR certification standard is the American Heart Association’s BLS Healthcare Providers Course or its equivalent, as determined by the Board. This CPR course must be a hands-on course; online CPR courses will not be approved by the Board for initial CPR certification;

(A) After the initial CPR certification, the Board will accept a Board-approved BLS Healthcare Providers Online Renewal course for license renewal. A CPR certification card with an expiration date must be received from the CPR provider as documentation of CPR certification;

(B) The Board considers the CPR expiration date to be the last day of the month that the CPR instructor indicates that the certification expires;

(C) Documentation of CPR certification is due with the licensee’s annual license renewal as indicated in OAR 852-050-0006. Failure to maintain current CPR certification will result in immediate automatic loss of Nontopical TPA certification. The Nontopical TPA certification will not be reinstated until the CPR certification deficiency has been corrected;

(D) Any licensee whose Nontopical TPA certification is lost due to expiration of their CPR certification is subject to a late CPR fee of $50 to have the Nontopical TPA certification reinstated. The fee must be received before the Nontopical TPA certification will be reinstated.

(5) Nontopical TPA Certification with Injections (ATI) for inactive status licensee: Before using nontopical therapeutic pharmaceutical agents with injections as listed in this rule, any optometric physician licensed in Oregon in inactive status must:

(a) Pass a didactic Nontopical TPA course of at least 23 hours approved by the Board or pass the National Board of Examiners in Optometry’s “Treatment and Management of Ocular Disease” (TMOD) year 2002 or subsequent examination;

(b) Pass a Nontopical TPA injection workshop of at least seven hours approved by the Board or provide proof of equivalent training acceptable to the Board;

(c) Pay a $75 TPA examination and licensure fee for nontopical TPA certification;

(d) Obtain a license from the Oregon Board of Optometry indicating “Certified to use Topical and Nontopical Therapeutic Pharmaceutical Agents with Injections”; and

(e) Acquire Board-Approved CPR certification designed for professional healthcare providers. The CPR certification must be the American Heart Association’s BLS Healthcare Providers Course or its equivalent, as determined by the Board. This must be a hands-on course; online CPR courses will not be approved by the Board for initial CPR certification. A CPR certification card with an expiration date must be received from the CPR provider as documentation of CPR certification. The Board considers the CPR expiration date to be the last day of the month that the CPR instructor indicates that the certification expires.

Stat. Auth.: ORS 683 & 182
Stats. Implemented: ORS 683.270 & 182.466
Hist.: OP 1-1994, f. 5-4-94, cert. ef. 5-9-94; OPT 2-1999, f.12-29-99, cert. ef.1-1-00; OPT 1-2002, f. & cert. ef. 7-26-02; OPT 3-2003, f. 9-15-03, cert. ef. 10-1-03; OPT 3-2004, f. 9-24-04, cert. ef. 10-1-04; OPT 2-2005, f. & cert. ef. 4-8-05; OPT 2-2006, f. 3-20-06, cert. ef. 4-1-06; OPT 4-2006, f. & cert. ef. 8-2-06; OPT 1-2007, f. 5-21-07, cert. ef. 7-1-07; OPT 1-2013, f. & cert. ef. 1-3-13

The official copy of an Oregon Administrative Rule is contained in the Administrative Order filed at the Archives Division, 800 Summer St. NE, Salem, Oregon 97310. Any discrepancies with the published version are satisfied in favor of the Administrative Order. The Oregon Administrative Rules and the Oregon Bulletin are copyrighted by the Oregon Secretary of State. Terms and Conditions of Use

Oregon Secretary of State • 136 State Capitol • Salem, OR 97310-0722
Phone: (503) 986-1523 • Fax: (503) 986-1616 • oregon.sos@state.or.us

© 2013 State of Oregon All Rights Reserved​